Physicochemical factors for cytotoxic activity in platinum dinuclear complexes with pyrimidine and imide ligands

Biophysical Chemistry

Volumn 75, Issue 3, 1998, Pages 259-270

  Kodaka, Masato ^a   Dohta, Yukifumi ^a,b   Rekonen, Petri ^a   Okada, Tomoko ^a   Okuno, Hiroaki ^a  

^a NATL INST BIOSCI HUM TECHNOL   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Effect of serum protein; Electrophilicity; Hydrophobicity

Indexed keywords

IMIDE; LIGAND; PLATINUM; PLATINUM COMPLEX; PYRIMIDINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CYTOTOXICITY; DRUG PROTEIN BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS; BINDING SITES; BLOOD PROTEINS; CATTLE; CHEMISTRY, PHYSICAL; CISPLATIN; ELECTROCHEMISTRY; IMIDES; LIGANDS; MICE; MODELS, BIOLOGICAL; PLATINUM COMPOUNDS; PROTEIN BINDING; PYRIMIDINES; SARCOMA 180; SERUM ALBUMIN, BOVINE; TUMOR CELLS, CULTURED;

EID: 0031740029     PISSN: 03014622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-4622(98)00213-0     Document Type: Article

References (23)

1. Rosenberg B., Van Camp L., Trosco J.E., Mansour V.H. Nature. 222:1969;385.
2. Woollins J.D., Rosenberg B. J. Inorg. Biochem. 19:1963;41.
3. Rekonen P., Dohta Y., Kodaka M., Okada T., Okamoto K., Okuno H. J. Med. Chem. 40:1997;515.
4. Dohta Y., Kodaka M., Okada T., Okamoto K., Okuno H. Inorg. Chim. Acta. 252:1996;5.
5. Dohta Y., Browning C.S., Rekonen P.et al. Inorg. Chim. Acta. 263:1997;69.
6. Hansch C., Fujita T. J. Am. Chem. Soc. 86:1964;1616.
7. Kelland L.R., Clarke S.J., McKeage M.J. Platinum Metals Rev. 36:1992;178.
8. T. Abe, H. Moriyama, K. Matsumoto, Chem. Lett. (1989) 1857.
9. Sherman S.E., Lippard S.J. Chem. Rev. 87:1987;1153.
10. Urata H., Moriyama H., Matsumoto K. Inorg. Chem. 30:1991;3914.
11. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Cancer Res. 47:1987;936.
12. Mistry P., Kelland L.R., Loh S.Y., Abel G., Murrer B.A., Harrap K.R. Cancer Res. 52:1992;6188.
13. Wiechelman K.J., Braun R.D., Fitzpatrick J.D. Anal. Biochem. 175:1988;231.
14. Yamaguchi C., Takami H., Yamamoto K., Miyoshi K., Takao N. Chem. Pharm. Bull. 32:1984;4994.
15. Ohmori T., Morikage T., Sugimoto Y.et al. Jpn. J. Cancer Res. 84:1993;83.
16. Andrews P.A., Howell S.B. Cancer Cells. 2:1990;35.
17. Gonias S.L., Pizzo S.V. J. Biol. Chem. 258:1983;5764.
18. Daley-Yates P.T., McBrien D.C. Biochem. Pharmacol. 33:1984;3063.
19. Hoshino T., Misaki M., Yamamoto M., Shimizu H., Ogawa Y., Toguchi H. J. Pharm. Sci. 84:1995;216.
20. Erickson L.E., Godfrey M., Larsen R.G. Inorg. Chem. 26:1987;992.
21. Miller S.E., House D.A. Inorg. Chim. Acta. 166:1989;189.
22. Matsunami J., Urata H., Matsumoto K. Inorg. Chem. 34:1995;202.
23. Ozawa S., Sugiyama Y., Mitsuhashi J., Kobayashi T., Inaba M. Cancer Chemother. Pharmacol. 21:1988;185.